Impact of Investment Withdrawal on UK Life Sciences

This chapter examines the fallout from a major US drugmaker's pullout from a key investment in London's King's Cross, revealing the challenges within the UK's life sciences sector. It includes government reactions to potential job losses and industry perspectives on the urgent need for strategies to enhance the UK's investment appeal.